The Outcome of Three Weeks Rehabilitation in Patients With a Total Hip or Knee Replacement Experiencing Persistent Physical Impairments (Rehab-hip-knee)

August 25, 2025 updated by: Jeppe Lange, Horsens Hospital
Patients with total hip or knee replacement experiencing persistant problems are offered 3 weeks of intensive rehabilitation.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Outcomes before, at the end of treatment and at 6 months follow up will be investigated. Data will be handled separately for the two groups of patients: 42 with a total hip replacement and 42 with a total knee replacement. Specific and generic outcomes will be collected.

Study Type

Observational

Enrollment (Estimated)

84

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Signe Kierkegaard-Brøchner, PhD
  • Phone Number: 004578427882
  • Email: signkier@rm.dk

Study Locations

      • Brædstrup, Denmark
        • Recruiting
        • Horsens Regional Hospital
        • Contact:
          • Signe Kierkegaard-Brøchner, PhD
          • Phone Number: 004578427882
          • Email: signkier@rm.dk
        • Principal Investigator:
          • Signe Kierkegaard-Brøchner, PhD
        • Sub-Investigator:
          • Stian Langgård Jørgensen, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who have a total hip or knee replacement experiencing persistant problems, hence are admitted to a 3 week intensive rehabilitation period.

Description

Inclusion Criteria:

- Patients with a total hip or knee replacement admitted for intensive rehabilitation

Exclusion Criteria:

  • Patients unable to understand Danish
  • Unable to participate in physical tests
  • Unable to understand questionaires
  • Unable to participate i 6 months follow up

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Intervention group hip
Patients with a total hip replacement undergoing rehabilitation
Three weeks intensive rehabilitation where patients undergo group-based and individualised rehabilitation focusing at improving pain, function and quality of life for the patient
Intervention group knee
Patients with a total hip replacement undergoing rehabilitation
Three weeks intensive rehabilitation where patients undergo group-based and individualised rehabilitation focusing at improving pain, function and quality of life for the patient

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HOOS/KOOS pain (0-100 score)
Time Frame: Change from baseline (0) to 3 weeks
Hip or knee related pain
Change from baseline (0) to 3 weeks
HOOS/KOOS ADL (0-100 score)
Time Frame: Change from baseline (0) to 3 weeks
Hip or knee related activities of daily living
Change from baseline (0) to 3 weeks
HOOS/KOOS quality of life (0-100 score)
Time Frame: Change from baseline (0) to 3 weeks
Hip or knee related quality of life
Change from baseline (0) to 3 weeks
HOOS/KOOS pain (0-100 score)
Time Frame: Change from 3 weeks to 7 months
Hip or knee related pain
Change from 3 weeks to 7 months
HOOS/KOOS ADL (0-100 score)
Time Frame: Change from 3 weeks to 7 months
Hip or knee related activities of daily living
Change from 3 weeks to 7 months
HOOS/KOOS quality of life (0-100 score)
Time Frame: Change from 3 weeks to 7 months
Hip or knee related quality of life
Change from 3 weeks to 7 months
Sit-to-stand test
Time Frame: Change from baseline (0) to 3 weeks
Number of completed sit to stands in 30 seconds
Change from baseline (0) to 3 weeks
Sit-to-stand test
Time Frame: Change from 3 weeks to 7 months
Number of completed sit to stands in 30 seconds
Change from 3 weeks to 7 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient acceptable symptom state (yes/no)
Time Frame: 3 weeks follow up
Patients are asked with a single question if their current symptom state is acceptable
3 weeks follow up
Patient acceptable symptom state (yes/no)
Time Frame: 7 months follow up
Patients are asked with a single question if their current symptom state is acceptable
7 months follow up
HOOS/KOOS symptoms (0-100 score)
Time Frame: Change from baseline (0) to 3 weeks
Hip or knee related symptoms
Change from baseline (0) to 3 weeks
HOOS/KOOS symptoms (0-100 score)
Time Frame: Change from 3 weeks to 7 months
Hip or knee symptoms
Change from 3 weeks to 7 months
HOOS/KOOS sport/rec (0-100 score)
Time Frame: Change from baseline (0) to 3 weeks
Hip or knee related sport/rec
Change from baseline (0) to 3 weeks
HOOS/KOOS sport/rec (0-100 score)
Time Frame: Change from 3 weeks to 7 months
Hip or knee related sport/rec
Change from 3 weeks to 7 months
6 minute walk test
Time Frame: Change from baseline (0) to 3 weeks
The distance a patient can walk in 6 minutes
Change from baseline (0) to 3 weeks
6 minute walk test
Time Frame: Change from 3 weeks to 7 months
The distance a patient can walk in 6 minutes
Change from 3 weeks to 7 months
40 meter fast paced walk test
Time Frame: Change from baseline (0) to 3 weeks
The time a patient uses walking 40 meters fast
Change from baseline (0) to 3 weeks
40 meter fast paced walk test
Time Frame: Change from 3 weeks to 7 months
The time a patient uses walking 40 meters fast
Change from 3 weeks to 7 months
Stair test
Time Frame: Change from baseline (0) to 3 weeks
The time a patient uses to ascend and decend a staircase
Change from baseline (0) to 3 weeks
Stair test
Time Frame: Change from 3 weeks to 7 months
The time a patient uses to ascend and decend a staircase
Change from 3 weeks to 7 months
Pain catastrophising scale (0-52 score)
Time Frame: Baseline
Current level of pain catastrophising with 0 being the best
Baseline
Pain catastrophising scale (0-52 score)
Time Frame: 3 weeks
Current level of pain catastrophising with 0 being the best
3 weeks
Pain catastrophising scale (0-52 score)
Time Frame: 7 months
Current level of pain catastrophising with 0 being the best
7 months
Global rating of change (0-11 score)
Time Frame: Change from baseline to 3 weeks
Likert scale where patients indicate their overall rating of change since the beginning of the intervention
Change from baseline to 3 weeks
Global rating of change (0-11 score)
Time Frame: Change from baseline to 7 months
Likert scale where patients indicate their overall rating of change since the beginning of the intervention
Change from baseline to 7 months
The 5-level EQ-5D version (EQ-5D-5L) (0-5 scale)
Time Frame: Change from baseline (0) to 3 weeks
EQ5D5L scores
Change from baseline (0) to 3 weeks
The 5-level EQ-5D version (EQ-5D-5L) (0-5 scale)
Time Frame: Change from 3 weeks to 7 mothns
EQ5D5L scores
Change from 3 weeks to 7 mothns
EQ5D VAS (0-100 scale)
Time Frame: Change from baseline (0) to 3 weeks
EQ5D Vas overall health
Change from baseline (0) to 3 weeks
EQ5D VAS (0-100 scale)
Time Frame: Change from 3 weeks to 7 months
EQ5D Vas overall health
Change from 3 weeks to 7 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient acceptable symptom state (yes/no)
Time Frame: Baseline
Patients are asked with a single question if their current symptom state is acceptable
Baseline
Employment status (yes/no/part time)
Time Frame: Baseline
Baseline
Employment status (yes/no/part time)
Time Frame: 7 months
7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 25, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

July 30, 2025

First Submitted That Met QC Criteria

July 30, 2025

First Posted (Actual)

August 6, 2025

Study Record Updates

Last Update Posted (Estimated)

August 26, 2025

Last Update Submitted That Met QC Criteria

August 25, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Osteoarthritis

Clinical Trials on Rehabilitation

3
Subscribe